Article Text

PDF

147 A case of dermatomyositis with elevated serum kl-6 level associated with ovarian cancer
  1. T Katagiri1,
  2. H Ito1,
  3. Y Fujisawa1,
  4. K Mizushina1,
  5. S Takenaka1,
  6. H Ayako1,
  7. T Ogura1,
  8. S Nagasaki2,
  9. S Komiyama2,
  10. T Oharaseki3 and
  11. H Kameda1
  1. 1Division of Rheumatology-Department of Internal Medicine, Toho University Ohashi Medical Cener, Meguro-ku, Japan
  2. 2Department of Gynaecology, Toho University Ohashi Medical Cener, Meguro-ku, Japan
  3. 3Department of Pathology, Toho University Ohashi Medical Cener, Meguro-ku, Japan

Abstract

Background and aims Elevated serum Krebs von den Lungen-6 (KL-6) is a biomarker of interstitial pneumonia and some types of cancers. Because patients with dermatomyositis (DM) may accompany interstitial pneumonia and malignancies, serum KL-6 level has been commonly examined for patients with DM in Japan.

Methods A 62-year-old woman developed myalgia in bilateral thighs in November 2014. She was admitted to our hospital in the following month because of progressive bilateral proximal muscle weakness and myalgia, elevated serum creatine kinase (CK: 5569 U/L), and Gottron’s papule. Although muscle biopsy had not been done, the diagnosis as DM was further supported by muscle MRI, electromyogram and skin biopsy. The body CT revealed pelvic mass with ascites, but not interstitial pneumonia.

Results Although prednisolone 50 mg/day and intravenous immunoglobulin therapy against progressive muscle weakness including severe dysphagia only showed a partial response, the surgical resection of ovarian mass, identified as ovarian serous adenocarcinoma stage II c, followed by chemotherapy resulted in clinical remission of DM. Serum KL-6 level, as well as CA-125 decreased below the upper normal limit.

Conclusions The present case suggests that the measurement of serum KL-6 may be useful in the evaluation of patients with DM.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.